Nomura Asset Management CO LTD Adma Biologics, Inc. Transaction History

Nomura Asset Management CO LTD

  • $31.8 Billion
  • Q3 2024
Number of Shares
0
Previous 0 NaN%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024
BUY
$11.21 - $20.03 $0 - $0
0 New
0 $0
Q2 2024

Aug 14, 2024
BUY
$5.98 - $11.18 $0 - $0
0 New
0 $0
Q1 2024

May 13, 2024
BUY
$4.4 - $6.74 $0 - $0
0 New
0 $0
Q4 2023

Feb 09, 2024
BUY
$3.08 - $4.52 $0 - $0
0 New
0 $0
Q3 2023

Nov 03, 2023
BUY
$3.47 - $4.61 $0 - $0
0 New
0 $0
Q2 2023

Aug 14, 2023
BUY
$3.12 - $4.22 $0 - $0
0 New
0 $0

Others Institutions Holding ADMA

# of Institutions
319
Shares Held
184M
Call Options Held
917K
Put Options Held
91.6K
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.51B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email